New Preventive Treatment

FDA APPROVES FIRST CGRP INHIBITOR FOR PREVENTION OF MIGRAINE ATTACKS
“For years the migraine community has been advocating for new treatment options that are specifically designed to treat migraine, a debilitating and often stigmatized disease. Today we celebrate the tireless work of researchers to better understand the biology of migraine and their ability to bring a new therapeutic approach to the millions of Americans who are seeking fewer migraine days. On behalf of the community, we would also like to thank the thousands of clinical trial patients whose unwavering commitment made this progress possible.”
-Kevin Lenaburg, Executive Director, CHAMP

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: